Vitamin D Testing Market | Top Trends and Key Players Analysis Report 2031

Vitamin D Testing Market Outlook 2031

The global vitamin D testing market was valued at US$ 605.3 Mn in 2021

The global market is projected to expand at a CAGR of 5.8 % from 2022 to 2031

The global vitamin D testing market is anticipated to reach more than US$ 1.06 Bn by the end of 2031

Vitamin D Testing Market Introduction

Rise in awareness about the consequences of nutritional deficiencies, increase in geriatric population, and rise in cases of chronic illnesses in both young and old population have driven the vitamin D testing market revenue in the last few years. Vitamin D is one of the vital nutrients required by the human body for good health, cell growth, and stronger teeth. Based on source, it is classified into two types - Vitamin D2, which is manmade and added to food, and Vitamin D3, which is synthesized in the human skin and can also be found in animal-based food. Incidence of vitamin D deficiency is increasing due to minimum exposure to sunlight, low intake of vitamin D, poor absorption of food, and changes in lifestyles.

Furthermore, introduction of at-home testing kits and intravenous administration for quick results, combined with a rise in expenditure in the healthcare industry in various developing countries are expected to drive the vitamin D testing market size. The ability of vitamin D testing to identify bone malformations, bone softness, and weakness is also expected to increase the demand for testing, which is expected to have a positive impact on the market.

Request a Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=33557

Rise in Prevalence of Vitamin D Deficiency to Boost Market Growth

According to the National Center for Biotechnology Information (NCBI), Vitamin D deficiency is a global public health issue. Approximately one billion people worldwide have vitamin D deficiency, while 50% of the population has vitamin D insufficiency. Prevalence of patients with vitamin D deficiency is highest in the elderly, obese patients, nursing home residents, and hospitalized patients.

In the U.S., around 50% to 60% of nursing home residents and hospitalized patients had vitamin D deficiency. Vitamin D deficiency is known to be common in northern Europe, majorly in women with pigmented skin. The deficiency is reported to be three times more common in winter months as compared to that in other months in the U.K.

In the U.S., 47% of African-American infants and 56% of Caucasian infants have vitamin D deficiency, while over 90% of infants in Iran, Turkey, and India have vitamin D deficiency. In the adult population, 35% of adults in the U.S. are vitamin D deficient, while over 80% of adults in India and Bangladesh are Vitamin D deficient. In the U.S., 61% of the geriatric population is vitamin D deficient, whereas 90% in Turkey, 96% in India, and 67% in Iran were vitamin D deficient.

Request Report Methodology: https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=33557

Rise in prevalence of vitamin D and an increase in focus on its importance contribute to the rise in screening for vitamin D serum levels, thereby boosting the vitamin D testing market.

Increase in Geriatric Population to Propel Vitamin D Testing Market

According to data published by the United Nations Department of Economics and Social Affairs, the geriatric population is expected to double to nearly 2.1 billion by 2050. Geriatric population is prone to deficiency of vitamin D. Chronic diseases affecting skin integrity such as peripheral vascular diseases (arterial insufficiency & venous hypertension) and diabetes are becoming increasingly common with rise in geriatric population. Frequent consequences include skin breakdown with ulcer and chronic wound formation.

Increase in geriatric population is likely to triple or quintuple the demand for medical services and trigger the growth of non-communicable diseases (heart, cancer, and diabetes), which account for about 87% of the health issues faced by the aged population in low, middle, and high income countries. This situation also needs surgical interventions, consequently driving the vitamin D testing market. Increase in geriatric population and rise in vitamin D deficiency among this population is likely to boost the vitamin D testing market.

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=33557

High Demand for 25-Hydroxy Vitamin D Test to Augment Market

The 25-hydroxy vitamin D segment dominated the market, and accounted for a notable market share in 2021. The segment is anticipated to expand at a high CAGR during the forecast period. This segment is expected to remain dominant during the forecast period, both in terms of revenues and market share.

Expansion of the segment can be attributed to an increase in the number of tests being performed globally, ease of identification and estimation of 25-hydroxy D vitamin levels in the plasma serum owing to its longer half-life, even though it is present in smaller volumes. Furthermore, its ability to identify a range of bone disorders owing to the lack of recommended levels of vitamin D propel the segment.

ELISA Technique Serves as Lucrative Alternative for Early Detection of Vitamin D Deficiency

The ELISA segment dominated the market and held a prominent share of the global market in 2021. Growth of the segment is attributed to rapid automation of systems due to increase in vitamin D tests. ELISA is a completely automated technique for vitamin D tests.

Vitamin D deficiency (VDD) is a common health issue in women during the early stage of pregnancy. Various clinical trials using ELISA have been carried out to measure the concentrations of 25-hydroxy vitamin D. It has been proven that women usually suffer from vitamin D deficiency during early pregnancy. Thus, stakeholders in the vitamin D testing landscape need to innovate and develop preventive techniques and ways of early detection of VDD during early pregnancy.

Regional Outlook of Global Vitamin D Testing Market

North America held a major share of the global vitamin D testing market, in terms of revenue, in 2021. The region is projected to dominate the global market during the forecast period. Rise in prevalence of vitamin D deficiency, increase in prescriptions of vitamin D blood tests, surge in aging population, and rise in prevalence of vitamin D deficiency among the adult population boost the market in North America.

Europe is anticipated to be the second largest market in terms of share and revenue during the forecast period. Vitamin D deficiency is a public health issue in Germany. It is significantly prevalent in the adult as well as the younger population. Moreover, various studies conducted in Germany indicate that the average intake of vitamin D does not meet the recommended daily intake levels. These factors increase the number of vitamin D blood tests performed in the country; consequently, fueling the market.

Request For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=33557

The vitamin D testing market in Asia Pacific is expected to expand at a notable CAGR of 6.5% during the forecast period. Growth of the market in the region is attributed to an increase in the geriatric population, rise in prevalence of vitamin D deficiency, changing reimbursement scenario for these tests, and increase in focus of market players on strengthening their presence in the emerging economies.

Analysis of Key Players in Global Vitamin D Testing Market

Key manufacturers operating in the global vitamin D testing market are gaining a competitive edge in the market by emphasizing on mergers and tie-ups. Presently, the market is highly competitive, as large number of companies are aiming to capitalize on the expansion of the market. The global vitamin D testing market is fragmented, with the presence of large number of players. These include Bio-Rad Laboratories, Inc., Abbott Laboratories, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, DiaSys Diagnostic Systems GmbH, DiaSorin, bioMérieux, Siemens AG, Quest Diagnostics, Danaher Corporation, and OmegaQuant.

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

This release was published on openPR.